Can the prophylactic use of raloxifene, a selective estrogen-receptor modulator, prevent bone mineral loss and fractures in women with diagnosed osteoporosis or vertebral fractures?

B. Ettinger; D. M. Black; B. H. Mitlak; J. A. Rosenfeld

doi:10.1136/ewjm.173.3.186

Can the prophylactic use of raloxifene, a selective estrogen-receptor modulator, prevent bone mineral loss and fractures in women with diagnosed osteoporosis or vertebral fractures?

B. Ettinger, D. M. Black, B. H. Mitlak, J. A. Rosenfeld

Research output: Contribution to journal › Article › peer-review

Original language	English (US)
Pages (from-to)	186-188
Number of pages	3
Journal	Western Journal of Medicine
Volume	173
Issue number	3
DOIs	https://doi.org/10.1136/ewjm.173.3.186
State	Published - 2000
Externally published	Yes

ASJC Scopus subject areas

General Medicine

Access to Document

10.1136/ewjm.173.3.186

Cite this

@article{d9dda852ee4c45428630f55e82579790,

title = "Can the prophylactic use of raloxifene, a selective estrogen-receptor modulator, prevent bone mineral loss and fractures in women with diagnosed osteoporosis or vertebral fractures?",

author = "B. Ettinger and Black, {D. M.} and Mitlak, {B. H.} and Rosenfeld, {J. A.}",

year = "2000",

doi = "10.1136/ewjm.173.3.186",

language = "English (US)",

volume = "173",

pages = "186--188",

journal = "Western Journal of Medicine",

issn = "0093-0415",